- Systemic adjuvant therapy in breast cancer
-
Ahn JH, Kim SB, Kim WK
- KMID: 1984657
- Korean J Med.
- 2005 Sep;69(3):243-254.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient
-
Hamdy O
- KMID: 2441860
- J Breast Cancer.
- 2019 Mar;22(1):149-152.
- doi: 10.4048/jbc.2019.22.e3
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
-
Li X, Wang M, Wang M, Yu X, Guo J, Sun T, Yao L, Zhang Q, Xu Y
- KMID: 2470889
- J Breast Cancer.
- 2019 Dec;22(4):497-521.
- doi: 10.4048/jbc.2019.22.e49
Currently, neoadjuvant chemotherapy is a standard therapeutic strategy for breast cancer, as it can provide timely and individualized chemo-sensitivity information and is beneficial for custom-designing subsequent treatment strategies. To accurately... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical effects of neoafjuvant chemotherapy in stage IIIA non-small cell lung cancer
-
Jeong SS, Kang DW, Lee GS, Ko DS, Suh JC, Kim GH, Kim JO, Kim SY
- KMID: 2251366
- Korean J Med.
- 1999 Aug;57(2):183-190.
BACKGROUND: Surgical therapy remains the only curative treatment of localized non-small cell lung cancer(NSCLC). But the efficacy of surgery for patients with NSCLC is limited, although recent studies suggest that... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in the Neoadjuvant Treatment of Breast Cancer
-
Rubovszky , Horváth Z
- KMID: 2389749
- J Breast Cancer.
- 2017 Jun;20(2):119-131.
- doi: 10.4048/jbc.2017.20.2.119
In the last few decades, neoadjuvant therapy for breast cancer has gained considerable therapeutic importance. Despite extensive clinical investigations, it has not yet been clarified whether neoadjuvant therapy would result... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathologic Evaluation of Breast Cancer after Neoadjuvant Therapy
-
Park CK, Jung WH, Koo JS
- KMID: 2164593
- J Pathol Transl Med.
- 2016 May;50(3):173-180.
- doi: 10.4132/jptm.2016.02.02
Breast cancer, one of the most common cancers in women, has various treatment modalities. Neoadjuvant therapy (NAT) has been used in many clinical trials because it is easy to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
- Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer
-
Shin GW, Park YM, Yoon HK, Jung SJ, Kim TH, Lee A, Lee SM
- KMID: 2362934
- J Breast Cancer.
- 2016 Dec;19(4):459-464.
- doi: 10.4048/jbc.2016.19.4.459
In patients with advanced breast cancer, most new calcifications detected on a mammogram after neoadjuvant chemotherapy are benign dystrophic calcifications, but this is not always observed. We present a patient... -
- CITED
-
- Close
- SHARE
-
- Close
- Influences of Neoadjuvant Androgen Ablation before Radical Prostatectomy on Positive Surgical Margin and Biochemical Recurrence Rate
-
Park EK, Chung BH, Hong SJ
- KMID: 2293267
- Korean J Urol.
- 2004 Jun;45(6):518-523.
PURPOSE: For patients with a localized prostate cancer, the effects of neoadjuvant hormonal therapy are controversial. We evaluated the resection margin status and progression-free survival in high-risk patients (clinical stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation between EGFR and c-erbB-2 oncoprotein status and response to neoadjuvant chemotherapy in cervical carcinoma
-
Kim JW, Kim YT, Kim DK
- KMID: 711638
- Yonsei Med J.
- 1999 Jun;40(3):207-214.
- doi: 10.3349/ymj.1999.40.3.207
Neoadjuvant chemotherapy prior to definitive radical surgery or radiotherapy may be effective in reducing tumor volume or clinical stage and may even enhance pelvic control and survival. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of Neoadjuvant Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer
-
Lee WJ, Woo SM
- KMID: 2448525
- Korean J Pancreas Biliary Tract.
- 2016 Jul;21(3):117-127.
- doi: 10.15279/kpba.2016.21.3.117
Surgical resection offers the only chance of cure for nonmetastatic exocrine pancreatic cancer. However, only 15 to 20 percent of patients have potentially resectable disease at diagnosis; approximately 40 percent... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver Transplantation for the Curative Treatment of Hilar Cholangiocarcinoma: Model of the Mayo Clinic
-
Ahn KS, Kang KJ
- KMID: 1435075
- J Korean Soc Transplant.
- 2012 Mar;26(1):1-5.
- doi: 10.4285/jkstn.2012.26.1.1
Liver transplantation for treating cholangiocarcinoma (CCA) has potential benefits in terms of accomplishing radical resection even in patients with unresectable tumor and treating underlying disease such as primary sclerosing cholangitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
-
An JY, Kim HI, Cheong JH, Hyung WJ, Kim CB, Noh SH
- KMID: 2158222
- Yonsei Med J.
- 2013 Jul;54(4):888-894.
- doi: 10.3349/ymj.2013.54.4.888
PURPOSE: Although neoadjuvant therapy has been accepted as a treatment option in locally-advanced gastric cancer, its prognostic value has been difficult to evaluate. MATERIALS AND METHODS: Seventy-four gastric cancer patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant Treatment for Gastric Cancer
-
Schuhmacher C, Reim D, Novotny A
- KMID: 2372375
- J Gastric Cancer.
- 2013 Jun;13(2):73-78.
Surgery is still considered to be the mainstay for the treatment of localized gastric cancer with negative margins (R0-resection) and an adequate lymph-node-dissection (D2-lymphadenectomy). Unfortunately, most cases of gastric cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer
-
Lee SJ, Lee JW, Park CS, Kim BG, Lee JH, Bae DS
- KMID: 2272299
- Korean J Obstet Gynecol.
- 2004 Apr;47(4):627-633.
OBJECTIVE: Neoadjuvant chemotherapy has been proposed as an alternative approach to conventional radical surgery with an aim to improve morbidity and survival. General acceptance of neoadjuvant chemotherapy as an alternative... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Curative Resection of Advanced Combined Hepatocellular-cholangiocarcinoma after Neoadjuvant Chemotherapy
-
Choi JE, Kim KH, Kim SA, Lee JH, Woo SM, Park SJ, Hong EK, Lee WJ
- KMID: 2448522
- Korean J Pancreas Biliary Tract.
- 2016 Apr;21(2):101-106.
- doi: 10.15279/kpba.2016.21.2.101
Combined hepatocellular-cholangiocarcinoma (HCC-CC) is a primary liver cancer with histopathologic features of both hepatocelluar carcinoma and cholangiocarcinoma. As combined HCC-CC has been associated with poor outcomes, accurate diagnosis and proper... -
- CITED
-
- Close
- SHARE
-
- Close
- Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes
-
Park SW, Kim JS, Kim JY, Lee KH
- KMID: 2412400
- Ann Surg Treat Res.
- 2018 Jun;94(6):306-311.
- doi: 10.4174/astr.2018.94.6.306
PURPOSE: The aim of this study was to evaluate the long-term outcome of additional 4-week chemotherapy with capecitabine during the resting periods following a 6-week neoadjuvant chemoradiotherapy (NCRT) regimen, in... -
- CITED
-
- Close
- SHARE
-
- Close
- Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update
-
Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, Shah M
- KMID: 2438987
- J Breast Cancer.
- 2017 Sep;20(3):217-227.
- doi: 10.4048/jbc.2017.20.3.217
Sentinel lymph node biopsy has become a standard staging tool in the surgical management of breast cancer. The positive impact of sentinel lymph node biopsy on postoperative negative outcomes in... -
- CITED
-
- Close
- SHARE
-
- Close
- Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
-
Kim KI, Lee KH, Kim TR, Chun YS, Lee TH, Park HK
- KMID: 2353082
- J Breast Cancer.
- 2014 Mar;17(1):40-46.
PURPOSE: The objectives of this study were to assess the potential value of Ki-67 in predicting response to neoadjuvant chemotherapy in breast cancer patients and to suggest a reasonable cutoff... -
- CITED
-
- Close
- SHARE
-
- Close
- Upper eyelid Merkel cell carcinoma treated with neoadjuvant chemotherapy and surgical excision
-
Toto V, Colapietra A, Alessandri-Bonetti M, Vincenzi B, Devirgiliis V, Panasiti V, Persichetti P
- KMID: 2447636
- Arch Craniofac Surg.
- 2019 Apr;20(2):121-125.
- doi: 10.7181/acfs.2018.02089
Merkel cell carcinoma is a rare cutaneous carcinoma, featured by an aggressive clinical course and a mortality rate of 28% at 2 years. A 71-year-old female was affected by a... -
- CITED
-
- Close
- SHARE
-
- Close
- Bronchus perforation by EZ-Blockerâ„¢ endobronchial blocker during esophageal resection after neoadjuvant chemoradiation: a case report
-
van de Pas JM, van der Woude MC, Belgers HJ, Hulsewé K, de Loos ER
- KMID: 2447514
- Korean J Anesthesiol.
- 2019 Apr;72(2):184-187.
- doi: 10.4097/kja.d.18.00237
BACKGROUND: Double-lumen tubes (DLT) and endobronchial blockers (EB) are used for one-lung ventilation in thoracic surgery. More complications are seen when using DLT when compared to EB, while major complications... -
- CITED
-
- Close
- SHARE
-
- Close
